Omidria 2.88 mg/mL
phenylephrine and ketorolac · INJECTION, SOLUTION, CONCENTRATE · Omeros Corporation
Omidria is a injection, solution, concentrate containing phenylephrine and ketorolac at 2.88 mg/mL, taken intraocular. Manufactured by Omeros Corporation.
Key Facts
- Brand Name
- Omidria
- Generic Name
- phenylephrine and ketorolac
- NDC Code (Product)
62225-600- Manufacturer
- Omeros Corporation
- Strength
- 2.88 mg/mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAOCULAR
- Marketing Status
- Application #
- NDA205388
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]; Cyclooxygenase Inhibitor [EPC]
- Marketing Start
- 06/13/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Omidria used for?
Omidria contains phenylephrine and ketorolac. It is a injection, solution, concentrate taken intraocular. Consult your doctor for specific uses.
Is Omidria a controlled substance?
Omidria is not classified as a controlled substance by the DEA.
What is the generic name for Omidria?
The generic name for Omidria is phenylephrine and ketorolac. There are no other listed brand versions of phenylephrine and ketorolac.
What is the NDC code for Omidria 2.88 mg/mL?
The NDC (National Drug Code) for Omidria 2.88 mg/mL is 62225-600, listed by Omeros Corporation.
Product NDC
62225-600
Other Omidria Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)